TELEGRAPH HILL PARTNERS
TELEGRAPH HILL PARTNERS is a Series C+ fund in the US investing in life-science, medical-device, healthcare-tech and healthcare-services.
- Stages
- Series C+
- Sectors
- life-science, medical-device, healthcare-tech, healthcare-services
- Invests in
- US-wide
- Founded
- 2001
- Assets under management
- $1.0B
- Website
- thpartners.net
Check size not disclosed
Thesis
Telegraph Hill Partners (THP) is a venture capital firm founded in 2001 that focuses on providing growth capital to life science, medical device, and healthcare companies. The firm seeks to partner with companies that have validated technologies, a solid customer base, and innovative management teams. THP's investment strategy includes growth equity, acquisitions, and management buyouts, often acting as the first institutional investor for bootstrapped companies. THP primarily invests in North America. THP closed its fifth fund, THP V, in July 2022, raising $525 million. Telegraph Hill Partners III has a size of $310M.
Common questions
Does TELEGRAPH HILL PARTNERS invest at the Series C+ stage?
Yes. TELEGRAPH HILL PARTNERS lists Series C+ among the stages it invests in.
Where does TELEGRAPH HILL PARTNERS invest?
TELEGRAPH HILL PARTNERS invests in the US.